Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection

Colin ForsythFacundo Garcia-BournissenGuillermo MoscatelliSamanta MoroniAna Cristina PereiroLourdes Ortiz-DazaElvira-Idalia Hernández CuevasFreddy TinajerosTayná MarquesAndrea Marchiol2026-03-222026-03-22202610.1371/journal.pntd.0013597https://doi.org/10.1371/journal.pntd.0013597https://andeanlibrary.org/handle/123456789/79255The TPP provides guidance for essential and ideal characteristics of formulations of new drugs for the treatment of children with T. cruzi infection.enMedicineChagas diseaseIntensive care medicineSafety profileBiological drugsDrugImmunologyPharmacologyTrypanosoma cruziProduct (mathematics)Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infectionarticle